Literature DB >> 30679790

Tspan8-β-catenin positive feedback loop promotes melanoma invasion.

Manale El Kharbili1,2,3,4, Gweltaz Agaësse1,2,3, Laetitia Barbollat-Boutrand1,2,3,5, Roxane M Pommier5, Arnaud de la Fouchardière5,6, Lionel Larue7,8,9, Julie Caramel5, Alain Puisieux5, Odile Berthier-Vergnes1,2,3, Ingrid Masse10,11,12,13.   

Abstract

Due to its high proclivity to metastasize, and despite the recent development of targeted and immune therapy strategies, melanoma is still the deadliest form of skin cancer. Therefore, understanding the molecular mechanisms underlying melanoma invasion remains crucial. We previously characterized Tspan8 for its ability to prompt melanoma cell detachment from their microenvironment and trigger melanoma cell invasiveness, but the signaling events by which Tspan8 regulates the invasion process still remain unknown. Here, we demonstrated that β-catenin stabilization is a molecular signal subsequent to the onset of Tspan8 expression, and that, in turn, β-catenin triggers the direct transcriptional activation of Tspan8 expression, leading to melanoma invasion. Moreover, we showed that β-catenin activation systematically correlates with a high expression of Tspan8 protein in melanoma lesions from transgenic Nras; bcat* mice, as well as in deep penetrating naevi, a type of human pre-melanoma neoplasm characterized by a combined activation of β-catenin and MAP kinase signaling. Overall, our data suggest that β-catenin and Tspan8 are part of a positive feedback loop, which sustains a high Tspan8 expression level, conferring to melanoma cells the invasive properties required for tumor progression and dissemination.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30679790     DOI: 10.1038/s41388-019-0691-z

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  51 in total

1.  Tetraspanin CD63 acts as a pro-metastatic factor via β-catenin stabilization.

Authors:  Bastian Seubert; Haissi Cui; Nicole Simonavicius; Katja Honert; Sandra Schäfer; Ute Reuning; Mathias Heikenwalder; Bernard Mari; Achim Krüger
Journal:  Int J Cancer       Date:  2014-11-11       Impact factor: 7.396

2.  Differential LEF1 and TCF4 expression is involved in melanoma cell phenotype switching.

Authors:  Ossia M Eichhoff; Ashani Weeraratna; Marie C Zipser; Laurence Denat; Daniel S Widmer; Mai Xu; Lydia Kriegl; Thomas Kirchner; Lionel Larue; Reinhard Dummer; Keith S Hoek
Journal:  Pigment Cell Melanoma Res       Date:  2011-06-09       Impact factor: 4.693

3.  A large-scale RNAi screen identifies LCMR1 as a critical regulator of Tspan8-mediated melanoma invasion.

Authors:  G Agaësse; L Barbollat-Boutrand; E Sulpice; R Bhajun; M El Kharbili; O Berthier-Vergnes; F Degoul; A de la Fouchardière; E Berger; T Voeltzel; J Lamartine; X Gidrol; I Masse
Journal:  Oncogene       Date:  2016-07-04       Impact factor: 9.867

4.  Quantitative proteomics analysis of the role of tetraspanin-8 in the drug resistance of gastric cancer.

Authors:  Lan Li; Daping Yang; Dejun Cui; Yu Li; Zhao Nie; Jinglin Wang; Li Liang
Journal:  Int J Oncol       Date:  2017-12-19       Impact factor: 5.650

5.  Functional interplay between p63 and p53 controls RUNX1 function in the transition from proliferation to differentiation in human keratinocytes.

Authors:  I Masse; L Barbollat-Boutrand; M Molina; O Berthier-Vergnes; N Joly-Tonetti; M T Martin; C Caron de Fromentel; J Kanitakis; J Lamartine
Journal:  Cell Death Dis       Date:  2012-06-07       Impact factor: 8.469

6.  Association between the rat homologue of CO-029, a metastasis-associated tetraspanin molecule and consumption coagulopathy.

Authors:  C Claas; S Seiter; A Claas; L Savelyeva; M Schwab; M Zöller
Journal:  J Cell Biol       Date:  1998-04-06       Impact factor: 10.539

7.  p53 targets TSPAN8 to prevent invasion in melanoma cells.

Authors:  G Agaësse; L Barbollat-Boutrand; M El Kharbili; O Berthier-Vergnes; I Masse
Journal:  Oncogenesis       Date:  2017-04-03       Impact factor: 7.485

8.  Combined activation of MAP kinase pathway and β-catenin signaling cause deep penetrating nevi.

Authors:  Iwei Yeh; Ursula E Lang; Emeline Durieux; Meng Kian Tee; Aparna Jorapur; A Hunter Shain; Veronique Haddad; Daniel Pissaloux; Xu Chen; Lorenzo Cerroni; Robert L Judson; Philip E LeBoit; Timothy H McCalmont; Boris C Bastian; Arnaud de la Fouchardière
Journal:  Nat Commun       Date:  2017-09-21       Impact factor: 14.919

9.  Effect of an anti-human Co-029/tspan8 mouse monoclonal antibody on tumor growth in a nude mouse model.

Authors:  Naouel Ailane; Céline Greco; Yingying Zhu; Monica Sala-Valdés; Martine Billard; Ibrahim Casal; Olivia Bawa; Paule Opolon; Eric Rubinstein; Claude Boucheix
Journal:  Front Physiol       Date:  2014-09-19       Impact factor: 4.566

10.  Systematic large-scale meta-analysis identifies a panel of two mRNAs as blood biomarkers for colorectal cancer detection.

Authors:  Maria Teresa Rodia; Giampaolo Ugolini; Gabriella Mattei; Isacco Montroni; Davide Zattoni; Federico Ghignone; Giacomo Veronese; Giorgia Marisi; Mattia Lauriola; Pierluigi Strippoli; Rossella Solmi
Journal:  Oncotarget       Date:  2016-05-24
View more
  11 in total

1.  Long Non-Coding RNA THOR Enhances the Stem Cell-Like Traits of Triple-Negative Breast Cancer Cells Through Activating β-Catenin Signaling.

Authors:  Binbin Wang; Qiang Ye; Chuantao Zou
Journal:  Med Sci Monit       Date:  2020-07-14

2.  Tspan8 Drives Melanoma Dermal Invasion by Promoting ProMMP-9 Activation and Basement Membrane Proteolysis in a Keratinocyte-Dependent Manner.

Authors:  Manale El Kharbili; Muriel Cario; Nicolas Béchetoille; Catherine Pain; Claude Boucheix; Françoise Degoul; Ingrid Masse; Odile Berthier-Vergnes
Journal:  Cancers (Basel)       Date:  2020-05-21       Impact factor: 6.639

Review 3.  TSPAN8 as a Novel Emerging Therapeutic Target in Cancer for Monoclonal Antibody Therapy.

Authors:  Kyun Heo; Sukmook Lee
Journal:  Biomolecules       Date:  2020-03-03

Review 4.  The Context-Dependent Impact of Integrin-Associated CD151 and Other Tetraspanins on Cancer Development and Progression: A Class of Versatile Mediators of Cellular Function and Signaling, Tumorigenesis and Metastasis.

Authors:  Sonia Erfani; Hui Hua; Yueyin Pan; Binhua P Zhou; Xiuwei H Yang
Journal:  Cancers (Basel)       Date:  2021-04-21       Impact factor: 6.639

5.  ZEB1 transcription factor promotes immune escape in melanoma.

Authors:  Maud Plaschka; Valentin Benboubker; Maxime Grimont; Justine Berthet; Laurie Tonon; Jonathan Lopez; Myrtille Le-Bouar; Brigitte Balme; Garance Tondeur; Arnaud de la Fouchardière; Lionel Larue; Alain Puisieux; Yenkel Grinberg-Bleyer; Nathalie Bendriss-Vermare; Bertrand Dubois; Christophe Caux; Stéphane Dalle; Julie Caramel
Journal:  J Immunother Cancer       Date:  2022-03       Impact factor: 12.469

Review 6.  The role of mediator complex subunit 19 in human diseases.

Authors:  Yuting Zhang; Peifang Qin; Linlin Tian; Jianguo Yan; Yali Zhou
Journal:  Exp Biol Med (Maywood)       Date:  2021-05-26

7.  TSPAN8 and distant metastasis of nasopharyngeal carcinoma cells.

Authors:  Changqing Xie; Nicole A McGrath
Journal:  Ann Transl Med       Date:  2020-03

8.  A Positive Tetraspanin 8 (TSPAN8)/β-Catenin Regulatory Loop Enhances the Stemness of Colorectal Cancer Cells.

Authors:  Zhengyu Zhan; Luxing Zhong; Miao Feng; Yuling Guo
Journal:  Med Sci Monit       Date:  2019-12-15

9.  Extracellular vesicle tetraspanin-8 level predicts distant metastasis in non-small cell lung cancer after concurrent chemoradiation.

Authors:  Yang Liu; Jia Fan; Ting Xu; Navid Ahmadinejad; Kenneth Hess; Steven H Lin; Jianjun Zhang; Xi Liu; Li Liu; Bo Ning; Zhongxing Liao; Tony Y Hu
Journal:  Sci Adv       Date:  2020-03-11       Impact factor: 14.136

10.  Tetraspanin8 expression predicts an increased metastatic risk and is associated with cancer-related death in human cutaneous melanoma.

Authors:  Laetitia Barbollat-Boutrand; Roxane M Pommier; Odile Berthier-Vergnes; Arnaud de la Fouchardière; Patrick Combemale; Maxime Grimont; Noémie Lopez-Ramirez; Julie Caramel; Stéphane Dalle; Jean-Luc Perrot; Caroline Gaudy-Marqueste; Nicolas Macagno; Sandrine Mansard; Fanny Bouquet; Ingrid Masse
Journal:  Mol Cancer       Date:  2021-10-02       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.